Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
Active, not recruiting · NCT03525262 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C) | Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, erectile dysfunction, male reproductive system disorder, physiological sexual disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-06-05 | NCT03525262 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Scientific Corporation | 148 |
| University of Texas Southwestern Medical Center | 295 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |
| Penn Medicine Radiation Oncology | Philadelphia | United States | 1 |
| Penrose Hospital | Colorado Springs | United States | 1 |
| Stony Brook University Cancer Center | Stony Brook | United States | 9 |
| UCSF ( Department of Radiation Oncology University of California San Francisco) | San Francisco | United States | 1 |
| University Of Colorado Hospital | Aurora | United States | 106 |
| University of Michigan- Michigan Medicine | Ann Arbor | United States | 1 |
| UT Southwestern Cancer Center | Dallas | United States | 1 |